TradingKey - British pharmaceutical giant GSK announced on June 9 that it will acquire U.S. biotechnology company Nuvalent (NUVL) for $10.6 billion in an all-cash deal to bolster its lung cancer drug pipeline. This transaction marks GSK's largest acquisition in over a decade and represents the first major strategic move under new CEO Luke Miels.

TradingKeyTue, Jun 9

US Pre-Market: Three Major Index Futures Rise, Nasdaq Leads. Micron Rises Over 4%, Over 10 Billion Acquisition Drives Nuvalent to Surge Nearly 40%

TradingKey - On Tuesday Eastern Time, the three major U.S. stock index futures rose in pre-market trading as AI chip stocks extended their recovery rally. A temporary cooling of tensions in the Middle East led to a pullback in oil prices, boosting market risk appetite. As of press time, Dow futures

TradingKeyTue, Jun 9